1. Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management
   Ping Jin et al, 2022, Journal of Hematology & Oncology CrossRef
2. Osthole exhibits an antitumor effect in retinoblastoma through inhibiting the PI3K/AKT/mTOR pathway via regulating the hsa_circ_0007534/miR-214-3p axis
   Xiufang Lv et al, 2022, Pharmaceutical Biology CrossRef
3. Nanosecond pulsed cold atmospheric plasma jet suppresses proliferation and migration of human glioblastoma cells via apoptosis promotion and EMT inhibition
   Jie Zhuang et al, 2023, Archives of Biochemistry and Biophysics CrossRef
4. The alpha-adrenergic antagonist prazosin promotes cytosolic siRNA delivery from lysosomal compartments
   Thijs Van de Vyver et al, 2023, Journal of Controlled Release CrossRef
5. The role of neurotransmitters in glioblastoma multiforme‐associated seizures
   Mohammad Taghi Joghataei et al, 2023, International Journal of Developmental Neuroscience CrossRef
6. Targeting EphA2: a promising strategy to overcome chemoresistance and drug resistance in cancer
   Rafaela Nasser Veiga et al, 2024, Journal of Molecular Medicine CrossRef
7. Application of the anthraquinone drug rhein as an axial ligand in bifunctional Pt(iv) complexes to obtain antiproliferative agents against human glioblastoma cells
   Elisabetta Gabano et al, 2022, Dalton Transactions CrossRef
8. The functional role of circular RNAs in the pathogenesis of retinoblastoma: a new potential biomarker and therapeutic target?
   Mohsen Karami Fath et al, 2023, Clinical and Translational Oncology CrossRef